News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Hengrui Pharmaceuticals (01276.HK) Declares Final Dividend of RMB0.20 per Share
Hengrui Pharmaceuticals (01276.HK) announced that, as the 2025 profit distribution plan has been approved at the shareholders meeting, it will distribute a cash dividend of RMB2 p...
Reset
Send
The window will close in 5 seconds
Hengrui Pharmaceuticals (01276.HK) Declares Final Dividend of RMB0.20 per Share
Close
Recommend
3
Positive
4
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Hengrui Pharmaceuticals (01276.HK)  -0.900 (-1.327%)    Short selling $12.97M; Ratio 16.982%   announced that, as the 2025 profit distribution plan has been approved at the shareholders meeting, it will distribute a cash dividend of RMB2 per 10 shares (tax inclusive) to all shareholders. The 2025 final dividend is denominated and declared in RMB, and will be paid in RMB to the Companys A-share shareholders, and in cash at HKD2.2828 per 10 H shares to H-share shareholders.

The 2025 final dividend is expected to be distributed to H-share shareholders on May 27, 2026. (hc/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-21 16:25.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.